Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Inventory Average (2022 - 2025)

InMed Pharmaceuticals' Inventory Average history spans 4 years, with the latest figure at $919352.5 for Q4 2025.

  • For Q4 2025, Inventory Average fell 20.86% year-over-year to $919352.5; the TTM value through Dec 2025 reached $919352.5, down 20.86%, while the annual FY2025 figure was $1.1 million, 22.9% down from the prior year.
  • Inventory Average reached $919352.5 in Q4 2025 per INM's latest filing, down from $925990.0 in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $2.1 million in Q3 2022 to a low of $887571.5 in Q2 2025.
  • Average Inventory Average over 4 years is $1.3 million, with a median of $1.2 million recorded in 2022.
  • Peak YoY movement for Inventory Average: crashed 44.64% in 2023, then rose 23.72% in 2024.
  • A 4-year view of Inventory Average shows it stood at $1.7 million in 2022, then plummeted by 44.64% to $938968.0 in 2023, then rose by 23.72% to $1.2 million in 2024, then dropped by 20.86% to $919352.5 in 2025.
  • Per Business Quant, the three most recent readings for INM's Inventory Average are $919352.5 (Q4 2025), $925990.0 (Q3 2025), and $887571.5 (Q2 2025).